Bioceres Crop Solutions Corp (NASDAQ:BIOX) is set to release its Q2 2025 earnings on Feb 12, 2025. The consensus estimate for Q2 2025 revenue is $129.50 million, and the earnings are expected to ...

View Bioceres Crop Solutions Corp. (BIOX) current and estimated P/E ratio data provided by Seeking Alpha.

Lake Street analyst Ben Klieve maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $5.55.

Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has raised €2.7 million from existing ...

Lake Street analyst Ben Klieve maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at $6.67.